This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.
At a glance
Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.
An open check means the public sources were not specific enough—not that the service failed the check.
Resumen en español
9amHealth para usuarios hispanohablantes
Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.
No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.
- si la cita concreta será en español;
- el coste mensual ordinario y qué incluye;
- la licencia estatal del profesional;
- el medicamento, la farmacia y el coste por separado.
Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.
Comparar proveedores para hispanohablantes en EE. UU. →How the program is structured
A whole-person cardiometabolic program often accessed through an employer or health plan. It integrates obesity specialists, pharmacists, dietitians, behavioral-health expertise, connected devices, at-home labs, prescription support, nutrition, and exercise rather than selling one public consumer medication bundle.
GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.
Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.
Service configuration
These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.
- Provider type
- Telehealth program
- Medicine context
- Confirm the current medicine and brand route
- Formats reviewed
- Injection · Oral medicine
- Funding routes
- Insurance support · Private pay
- Service features
- Coaching · Clinician support · Switching pathway · Home delivery
- Access check
- Confirm current state access
- Evidence status
- Primary sources reviewed
- Research depth
- 2 cited sources · 2 medicine rows · 5 open checks
Recurring cost breakdown
- Public consumer cash pricing is not disclosed on the reviewed page.
- Cost and eligibility commonly depend on employer or health-plan sponsorship.
- The program can include connected devices, at-home labs, prescriptions, specialist access, and personalized plans.
- Medication copays and benefit rules remain separate unless the sponsoring plan states otherwise.
- Medicine + dose
- Membership or consultation
- Delivery + supplies
- Labs + follow-up
- Renewal after offers
Medication and formulation matrix
| Medication | Form | Regulatory / program path | Published price view |
|---|---|---|---|
| Prescription weight-management medication, including GLP-1s when appropriate | Oral or injectable based on care plan | FDA-approved prescription pathway | Employer/plan benefit and pharmacy coverage dependent |
| Non-GLP cardiometabolic medication | Varies | Clinician-selected | Benefit dependent |
Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.
State-by-state availability
- The program operates as virtual US specialty care, but access depends on the sponsoring benefit and clinician licensure.
- Individual direct enrollment and state availability should be confirmed before comparing it with retail subscriptions.
Clinician access and follow-up cadence
- The care team includes board-certified obesity specialists, pharmacists, dietitians, and behavioral-health experts.
- Expert support is advertised as available at any time; an exact appointment cadence depends on the benefit and care plan.
Pharmacy and fulfillment
- 9amHealth supports prescription approval and delivery; patient accounts describe medication shipped to the door.
- The named pharmacy and delivery terms depend on benefit design.
Insurance and prior authorization
- The program helps obtain approval for prescriptions and labs.
- Employer/health-plan eligibility, formulary, prior authorization, and cost-sharing define practical access.
Cancellation, refund, and commitment
- No universal direct-consumer subscription cancellation rule is published because access is often benefit-sponsored.
- Confirm what happens when employment, plan eligibility, or program participation ends.
Labs, monitoring, and dose management
- At-home lab tests and connected devices are core advertised capabilities.
- The exact panel, frequency, and cost depend on the personalized plan and sponsor.
Maintenance and switching
- The integrated care model is designed for long-term obesity, diabetes, and heart-health management.
- A switch into or out of the program should preserve current prescriptions, labs, connected-device data, and pharmacy timing.
Program snapshot
Cardiometabolic virtual care
Profiled support: Ongoing clinician access, Coaching or behavior support.
Insurance help · Cash pay
Employer or health-plan access may materially change eligibility and net cost.
Verify before purchase
Confirm whether medication is dispensed through a partner pharmacy and how benefits are applied.
What the advertised program may include
- Virtual clinical care
- Cardiometabolic support
- Labs or monitoring where included
- Medication management when appropriate
Useful comparison signals
Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.
- Starting care and comparing first-provider requirements
- Switching providers or continuing an established treatment
- Ongoing clinician access
- Coaching or behavior support
Open evidence gaps
These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.
- Direct-consumer price
- Universal eligibility route
- Named pharmacy
- Fixed follow-up cadence
- Cancellation rules after benefit loss
Questions to ask before paying
- What is the ordinary recurring total after any introductory period?
- Does that total include clinician care, medication, supplies, labs, and shipping?
- Which clinician group and dispensing pharmacy will be responsible for my care?
- What happens to billing if I am not prescribed the advertised treatment?
- What records and timing do you require if I am switching from another provider?
Source ledger
Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.
Care team, connected devices, labs, prescriptions, support and outcomes
Platform and service terms